Effects of risedronate on bone marrow adipocytes in postmenopausal women

被引:55
作者
Duque, G. [1 ,2 ]
Li, W. [2 ]
Adams, M. [2 ]
Xu, S. [3 ]
Phipps, R. [4 ]
机构
[1] Nepean Hosp, Sydney Med Sch, Penrith, NSW 2750, Australia
[2] Univ Sydney, Aging Bone Res Program, Sydney Med School, Penrith, NSW, Australia
[3] Procter & Gamble Pharmaceut, Mason, OH USA
[4] Husson Univ, Bangor, ME USA
关键词
Adipocytes; Marrow fat; Osteoporosis; PPAR gamma; Risedronate; VITAMIN-D; ADIPOSE-TISSUE; STROMAL CELLS; OSTEOPOROSIS; FAT; DIFFERENTIATION; BISPHOSPHONATES; ALENDRONATE; MECHANISMS; REGULATORS;
D O I
10.1007/s00198-010-1353-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aminobisphosphonates promote osteoblastogenesis while inhibiting adipogenesis in vitro. Their effect on adipogenesis in vivo remains unknown. In this study, we demonstrate that risedronate prevents marrow fat infiltration in postmenopausal women after 3 years of treatment. Age-related bone loss is associated with high levels of adipogenesis within the bone marrow at the expense of osteoblast population. Bisphosphonates stimulate osteoblastogenesis while inhibiting adipogenesis in vitro. In the present study, we tested whether the effect of bisphosphonates on marrow adipogenesis in vitro is also seen in vivo. We analyzed transiliac bone biopsies from a randomized, placebo-controlled clinical trial that evaluated the effects of risedronate treatment 5 mg/day on vertebral and non-vertebral fractures in women with postmenopausal osteoporosis. Paired bone biopsies were obtained from a subset of patients at baseline and after treatment with placebo or risedronate for 3 years (n = 14 per group). Biopsies were stained with toluidine blue and hematoxylin/eosin. Adipocyte volume/tissue volume (AV/TV), mean adipocyte number (AD(#)), and mean adipocyte diameter (AD(diam)) were quantified. Finally, expression levels of the adipogenesis transcription factor peroxisome proliferator activator gamma 2 (PPAR gamma 2) within the bone marrow were quantified using immunohistochemistry. In the placebo group, AV/TV, AD(#), and AD(diam) significantly increased after 3 years (similar to similar to 15%, p < 0.01). In contrast, AD(diam) remained unchanged and AV/TV and AD(#) were significantly reduced (similar to 20%) in the risedronate group at 3 years (p < 0.01). These changes were associated with a significant reduction in PPAR gamma 2 expression in the bone marrow of risedronate-treated women. Risedronate reduces bone marrow fat in postmenopausal women. These findings are the first demonstration of an effect of bisphosphonates on marrow fat in humans in vivo. By regulating the amount of fat within the bone marrow, this effect may contribute to the beneficial effect of bisphosphonates on bone mass.
引用
收藏
页码:1547 / 1553
页数:7
相关论文
共 34 条
  • [1] Boivin G., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P538
  • [2] Reciprocal relation between marrow adiposity and the amount of bone in the axial and appendicular skeleton of young adults
    Di Iorgi, Natascia
    Rosol, Michael
    Mittelman, Steven D.
    Gilsanz, Vicente
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (06) : 2281 - 2286
  • [3] 1,25(OH)2D3 acts as a bone-forming agent in the hormone-independent senescence-accelerated mouse (SAM-P/6)
    Duque, G
    Macoritto, M
    Dion, N
    Ste-Marie, LG
    Kremer, R
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2005, 288 (04): : E723 - E730
  • [4] Vitamin D treatment of senescence accelerated mice (SAM-P/6) induces several regulators of stromal cell plasticity
    Duque, G
    Macoritto, M
    Kremer, R
    [J]. BIOGERONTOLOGY, 2004, 5 (06) : 421 - 429
  • [5] Vitamin D inhibits Fas ligand-induced apoptosis in human osteoblasts by regulating components of both the mitochondrial and Fas-related pathways
    Duque, G
    El Abdaimi, K
    Henderson, JE
    Lomri, A
    Kremer, R
    [J]. BONE, 2004, 35 (01) : 57 - 64
  • [6] DUQUE G, 2010, IBMS BONEKEY, V7, P108
  • [7] Duque G., 2007, BONEKEY OSTEOVISION, V4, P129, DOI DOI 10.1138/20070257
  • [8] Bone and fat connection in aging bone
    Duque, Gustavo
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2008, 20 (04) : 429 - 434
  • [9] Understanding the mechanisms of senile osteoporosis: New facts for a major geriatric syndrome
    Duque, Gustavo
    Troen, Bruce R.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2008, 56 (05) : 935 - 941
  • [10] Alendronate has an anabolic effect on bone through the differentiation of mesenchymal stem cells
    Duque, Gustavo
    Rivas, Daniel
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 (10) : 1603 - 1611